PREXA PHARMACEUTICALS INC

Profile

Company Names

PREXA PHARMACEUTICALS INC

Addresses

184 HIGH STREET, 4TH FLOOR, BOSTON, MA 02110

Phone Numbers

857-366-8462

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$3,257,173.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-04-15 
$3,257,173.00 
$7,007,173.00 
$3,750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
 
BEDNARSKI 
DIRECTOR
TARSA THERAPEUTICS, INC.   |  AMPLA PHARMACEUTICALS INC   |  SOLX INC   |  PREXA PHARMACEUTICALS INC   |  ACCUVEIN INC.   |  MVM IV LP   |  SOLX EUROPE LTD   |  BIOTHERANOSTICS, INC.   |  VERO BIOTECH INC.   |  NEUROLENS, INC.   |  MDXHEALTH SA   |  MVM VI LP   |  OPTINOSE, INC.   |  MVM J LP
CHARLES 
M 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
PREXA PHARMACEUTICALS INC
JASON 
 
FISHERMAN 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  AMPLA PHARMACEUTICALS INC   |  PREXA PHARMACEUTICALS INC   |  TRIDENT PHARMACEUTICALS INC   |  C4 THERAPEUTICS, INC.   |  ALLOMEK THERAPEUTICS, LLC   |  ZEKANO BIO, INC.
EVELYN 
 
GRAHAM 
EXECUTIVE OFFICER, DIRECTOR
CALCIMEDICA INC   |  PREXA PHARMACEUTICALS INC
THOMAS 
 
NEEDHAM 
EXECUTIVE OFFICER, DIRECTOR
PREXA PHARMACEUTICALS INC   |  TRIDENT PHARMACEUTICALS INC   |  RENOVACOR, INC.   |  BASKING BIOSCIENCES, INC.   |  KANTUM PHARMA, INC.
BRIAN 
 
PIPER 
DIRECTOR
PREXA PHARMACEUTICALS INC   |  AEVI GENOMIC MEDICINE, INC.   |  PRELUDE THERAPEUTICS INC   |  SCORPION THERAPEUTICS, INC.   |  ANTARES THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-04-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#